COMP <GO>
JAZZ vs JNJ // 10Y YIELD & FRED MACRO BETA
Jazz Pharmaceuticals plc Common Stock (Ireland) (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: JAZZ 2
— JNJ 10
▲ 10Y YIELD & FRED MACRO BETA LEADER: JAZZ
LAST: $215.98 (+3.92%) • MKT CAP: $13.49B
macro-sensitivity
1.09
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
macro-sensitivity
1.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JAZZ VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | JAZZ | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 67.90% | -26.90 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -4.70% | 25.50% | -30.20 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 9.61% | 2.97% | +6.64 | JAZZ | /fcf-yield <GO> |
| Operating Margin | -10.10% | 34.70% | -44.80 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -8.30% | 28.50% | -36.80 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 4.90% | 6.00% | -1.10 | JNJ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.97 | 5.59 | -3.62 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 7.20% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.4 | 60.4 | -13.97 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.09 | 1.08 | +0.01 | JAZZ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 23.0x | +13.00 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.49B | $662.49B | -$649.00B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | JAZZ REV | JNJ REV | JAZZ GROSS % | JNJ GROSS % | JAZZ FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.27B | $94.19B | 44.0% | 67.9% | $1.30B | $19.70B |
| FY 2024 | $4.07B | $88.82B | 44.0% | 69.1% | $1.36B | $19.84B |
| FY 2023 | $3.83B | $85.16B | 44.0% | 44.0% | $919.5M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JAZZ // BETA 1.09
JNJ // BETA 1.08